| Phase 4 |
| NCT07182422 |
AST-120 (Kremezin®) for the Renal Protection and Attenuation of Decline in Acute Kidney… |
Acute Kidney Disease |
Recruiting |
2025-09-19 |
| NCT06520410 |
Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries |
Retinopathy of Prematurity Both Eyes |
Recruiting |
2024-07-25 |
| NCT06145321 |
Continuous Versus Bolus Administration of G-CSF in Children With Cancer |
Pediatric Cancer |
Active, Not Recruiting |
2024-09-19 |
| Phase 3 |
| NCT06704893 |
Amniotic Suspension Allograft Injection for Knee Osteoarthritis |
Knee |
Recruiting |
2026-01-26 |
| NCT06507059 |
Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting… |
HIV-1-infection |
Recruiting |
2024-08-23 |
| Phase 2/3 |
| NCT02448992 |
Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive… |
Non-Small-Cell Lung Cancer (NSCLC) |
Recruiting |
2023-05-01 |
| NCT07425262 |
A Pilot Trial of Chinese Medicine for Patients With Dialytic Hypotension |
End Stage Renal Disease on Dialysis |
Not Yet Recruiting |
2026-02-25 |
| NCT06111443 |
Effect of Dapagliflozin on the Recurrence of Atrial Tachyarrhythmia in Patients… |
Atrial Fibrillation Recurrent |
Active, Not Recruiting |
2023-12-21 |
| Phase 2 |
| NCT06339424 |
Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular… |
Hepatocellular Carcinoma |
Recruiting |
2026-10-01 |
| NCT06999694 |
Proton Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC |
HCC - Hepatocellular Carcinoma |
Recruiting |
2026-10-01 |
| NCT06999707 |
Photon Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC |
HCC - Hepatocellular Carcinoma |
Recruiting |
2026-10-01 |
| NCT06605664 |
Hyperpolarized 13C-MRI in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy… |
Hepatocellular Carcinoma (HCC) |
Recruiting |
2026-09-29 |
| NCT07336147 |
Dostarlimab, Cisplatin and Etoposide in Combination With Radiotherapy in Sandwich… |
Female |
Recruiting |
2026-08-17 |
| NCT07364617 |
Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD |
Graft vs Host Disease |
Recruiting |
2026-05-22 |
| NCT06133062 |
Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular… |
Hepatocellular Carcinoma Non-resectable |
Recruiting |
2026-03-20 |
| NCT05582161 |
Efficacy Biomarkers of DAOIB for Dementia |
Dementia |
Recruiting |
2026-03-19 |
| NCT05764538 |
DAOIB for the Treatment of Brain Fog |
Long COVID |
Recruiting |
2026-03-19 |
| NCT06467539 |
Novel Augmentation of DAOIB and Antioxidant for Early Dementia |
Alzheimer Disease |
Recruiting |
2026-03-19 |
| NCT07307989 |
Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis |
Ischemic Stroke |
Recruiting |
2025-12-30 |
| NCT07827807 |
PEARL Trial: Partial TACE Enhancing Anti-tumor Response With Lenvatinib in Unresectable… |
Hepatocellular Carcinoma |
Not Yet Recruiting |
2026-09-18 |
| NCT06339411 |
Cerebrolysin After Reperfusion in Extended-window EndoVascular Thrombectomy |
Acute Ischemic Stroke |
Not Yet Recruiting |
2026-08-11 |
| NCT07168668 |
Partial Immune-boost TACE in unrEseCTable HCC Patients Under Systemic Treatment |
HCC |
Not Yet Recruiting |
2026-08-06 |
| NCT06193733 |
Dendritic Cell Vaccination to Prevent Hepatocellular Carcinoma Recurrence After Liver… |
Hepatocellular Carcinoma |
Active, Not Recruiting |
2026-07-24 |
| NCT07726329 |
Dendritic Cell-immunotherapy for Advanced Hepatocellular Carcinoma |
Liver Neoplasms |
Active, Not Recruiting |
2026-07-24 |
| NCT05181189 |
NMDA Enhancement Combined With Omega-3 for Early Dementia |
Omega 3 Fatty Acids |
Not Yet Recruiting |
2026-03-20 |